Drospirenone and estradiol and Moxetumomab pasudotox
Determining the interaction of Drospirenone and estradiol and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: drospirenone / estradiol
Brand name: Angeliq
Synonyms: Drospirenone and Estradiol
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Drospirenone and estradiol-Moxetumomab Pasudotox-tdfk
- Drospirenone and estradiol-Moxetumomab pasudotox-tdfk Intravenous
- Drospirenone and estradiol-Moxifloxacin
- Drospirenone and estradiol-Moxifloxacin (Systemic)
- Drospirenone and estradiol-Moxifloxacin Hydrochloride
- Drospirenone and estradiol-Moxifloxacin Injection
- Moxetumomab pasudotox-Drospirenone and ethinyl estradiol
- Moxetumomab pasudotox-Drospirenone, ethinyl estradiol, and levomefolate
- Moxetumomab pasudotox-DroTuss-CP
- Moxetumomab pasudotox-Droxia
- Moxetumomab pasudotox-Droxidopa
- Moxetumomab pasudotox-Dry Eye Omega Benefits